[HTML][HTML] Diagnostic accuracy of liquid biomarkers for clinically significant prostate cancer detection: a systematic review and diagnostic meta-analysis of multiple …

T Kawada, SR Shim, F Quhal, P Rajwa… - European Urology …, 2023 - Elsevier
Context Many liquid biomarkers have entered clinical practice with the praise to improve the
detection of clinically significant prostate cancer (csPCa), helping avoid unnecessary …

Prostate cancer: genetics, epigenetics and the need for immunological biomarkers

G Rafikova, I Gilyazova, K Enikeeva, V Pavlov… - International Journal of …, 2023 - mdpi.com
Epidemiological data highlight prostate cancer as a significant global health issue, with high
incidence and substantial impact on patients' quality of life. The prevalence of this disease is …

The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer

YH Fan, PH Pan, WM Cheng, HK Wang, SH Shen… - Scientific reports, 2021 - nature.com
To evaluate the performance of the Prostate Health Index (PHI) in magnetic resonance
imaging-transrectal ultrasound (MRI-TRUS) fusion prostate biopsy for the detection of …

Aberrant sialylation in ovarian cancers

WL Lee, PH Wang - Journal of the Chinese Medical Association, 2020 - journals.lww.com
Sialylation (the covalent addition of sialic acid to the terminal end of glycoproteins or
glycans), tightly regulated cell-and microenvironment-specific process and orchestrated by …

[HTML][HTML] Molecular biomarkers for the detection of clinically significant prostate cancer: a systematic review and meta-analysis

T Del Pino-Sedeno, D Infante-Ventura… - European Urology Open …, 2022 - Elsevier
Abstract Context Prostate cancer (PCa) is the second most common type of cancer in men.
Individualized risk stratification is crucial to adjust decision-making. A variety of molecular …

Prostate cancer screening: Continued controversies and novel biomarker advancements

A Tidd-Johnson, SA Sebastian, M Afaq… - Current …, 2022 - journals.lww.com
Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and
public health. Despite being the second most common cancer in men worldwide …

Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy …

W Jia, B Wu, Y Shao, X Cao… - International Journal of …, 2021 - Wiley Online Library
Objective To evaluate the diagnostic value of prostate cancer antigen 3 and the Prostate
Health Index for the detection of overall and clinically significant prostate cancer at initial …

Utility of PSA isoform-[-2] proPSA (p2PSA) and prostate health index in the diagnosis of prostate cancer: A study in Indian population.

GR NL, P Bhat - Journal of Krishna Institute of Medical …, 2022 - search.ebscohost.com
Background: Measurement of serum total Prostate Specific Antigen (tPSA) for diagnosis of
Prostate Cancer (PC) has some limitations since PSA is organ-specific and not disease …